6108 Stock Chart & Stats
HK$0.36
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.36
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.19 - HK$0.47
Previous CloseN/A
Volume72.00K
Average Volume (3M)172.46K
Market Cap
HK$42.13M
Enterprise ValueHK$20.21
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding200,616,670
10 Day Avg. Volume113,360
30 Day Avg. Volume172,456
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
New Ray Medicine International Holding Ltd. News
6108 FAQ
What was New Ray Medicine International Holding Ltd.’s price range in the past 12 months?
New Ray Medicine International Holding Ltd. lowest stock price was HK$0.18 and its highest was HK$0.47 in the past 12 months.
What is New Ray Medicine International Holding Ltd.’s market cap?
New Ray Medicine International Holding Ltd.’s market cap is HK$42.13M.
When is New Ray Medicine International Holding Ltd.’s upcoming earnings report date?
New Ray Medicine International Holding Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 18 days.
How were New Ray Medicine International Holding Ltd.’s earnings last quarter?
New Ray Medicine International Holding Ltd. released its earnings results on Mar 25, 2026. The company reported -HK$0.063 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is New Ray Medicine International Holding Ltd. overvalued?
According to Wall Street analysts New Ray Medicine International Holding Ltd.’s price is currently Overvalued.
Does New Ray Medicine International Holding Ltd. pay dividends?
New Ray Medicine International Holding Ltd. does not currently pay dividends.
What is New Ray Medicine International Holding Ltd.’s EPS estimate?
New Ray Medicine International Holding Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Ray Medicine International Holding Ltd. have?
New Ray Medicine International Holding Ltd. has 200,616,670 shares outstanding.
What happened to New Ray Medicine International Holding Ltd.’s price movement after its last earnings report?
New Ray Medicine International Holding Ltd. reported an EPS of -HK$0.063 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of New Ray Medicine International Holding Ltd.?
Currently, no hedge funds are holding shares in HK:6108
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
Technical Analysis
China Healthwise Holdings
―
Raily Aesthetic Medicine International Holdings Limited
―
Universal Health International Group Holding Ltd.
―
China Regenerative Medicine International Limited
―
Medicskin Holdings Ltd.
―